Journal of Nippon Medical School: Vol.70 No.4 page.307

Journal of Nippon Medical School

Select Language
in Japanese < > in English

Full Text of this Article

in English PDF (292K)

ArticleTitle Effect of Prostaglandin E₁ on Contrast Enhanced CT of the Liver: Statistical Analysis During Arterial Portography

AuthorList Yutaka Abe, Satoru Murata, Hiroyuki Tajima, Hiromitsu Hayashi and Tatsuo Kumazaki

Affiliation Department of Radiology, Nippon Medical School
Center for Advanced Medical Technology, Nippon Medical School

Language EN

Volume 70

Issue 4

Year 2003

Page 307-312

Received January 21, 2002

Accepted January 14, 2003

Keywords liver, neoplasm, CT, portography

Abstract Purpose: To determine the diagnostic effect of prostaglandin E₁ on contrast enhancement quality of CT during arterial portography (CTAP).
Materials and Methods: Our patients population included 30 patients (11 women, 19 men; age range, 41∼81 years) with liver tumors (23 hepatocellular carcinoma and 7 metastatic liver tumor) who had undergone angiography. We divided the 30 patients, who had undertaken CTAP twice, into two groups at random (group A; n=15, group B; n=15). In group A, first CTAP was performed without prostaglandin E₁. Approximately 5 minutes later, a second CTAP was again initiated 30 seconds after injection of prostaglandin E₁ under the same conditions. In group B, prostaglandin E₁ was injected before the first CTAP only. We measured the mean CT numbers and standard deviation (SD) numbers of anterior, posterior, medial and lateral segments in the liver at the same section of the CTAP using the same size and location of the regions of interest, and these values with and without prostaglandin E₁ were compared.
Results: 1) CT numbers: The CT numbers were significantly increased in the medial segment after the injection of prostaglandin E₁ (p<0.05) in all cases of both groups. On the other hand, they were clearly decreased in the posterior segment after the injection of prostaglandin E₁ (p<0.05) in both groups. There were no statistical differences in the CT numbers in the anterior and lateral segments in all patients. In addition, the CT numbers of anterior and posterior segments showed high attenuation compared with the medial and lateral segments in group A without prostaglandin E₁. 2) SD numbers: The SD numbers, which are an index of the homogeneous enhancement, were significantly decreased in the posterior, medial and lateral segments after the injection of prostaglandin E₁ (p<0.01, p<0.05, p<0.01, respectively) in both groups. There were no significant differences in the SD numbers in the anterior segment regardless of the injection of prostaglandin E₁ in all cases.
Conclusion: CTAP with injection of prostaglandin E₁ makes contrast enhancement of liver parenchyma more homogeneously than the conventional procedure, and it may be a useful technique for the detection of liver tumors.

Correspondence to Yutaka Abe, MD, Department of Radiology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
y-abe@nms.ac.jp

ArticleTitle	Effect of Prostaglandin E₁ on Contrast Enhanced CT of the Liver: Statistical Analysis During Arterial Portography
AuthorList	Yutaka Abe, Satoru Murata, Hiroyuki Tajima, Hiromitsu Hayashi and Tatsuo Kumazaki
Affiliation	Department of Radiology, Nippon Medical School Center for Advanced Medical Technology, Nippon Medical School
Language	EN
Volume	70
Issue	4
Year	2003
Page	307-312
Received	January 21, 2002
Accepted	January 14, 2003
Keywords	liver, neoplasm, CT, portography
Abstract	Purpose: To determine the diagnostic effect of prostaglandin E₁ on contrast enhancement quality of CT during arterial portography (CTAP). Materials and Methods: Our patients population included 30 patients (11 women, 19 men; age range, 41∼81 years) with liver tumors (23 hepatocellular carcinoma and 7 metastatic liver tumor) who had undergone angiography. We divided the 30 patients, who had undertaken CTAP twice, into two groups at random (group A; n=15, group B; n=15). In group A, first CTAP was performed without prostaglandin E₁. Approximately 5 minutes later, a second CTAP was again initiated 30 seconds after injection of prostaglandin E₁ under the same conditions. In group B, prostaglandin E₁ was injected before the first CTAP only. We measured the mean CT numbers and standard deviation (SD) numbers of anterior, posterior, medial and lateral segments in the liver at the same section of the CTAP using the same size and location of the regions of interest, and these values with and without prostaglandin E₁ were compared. Results: 1) CT numbers: The CT numbers were significantly increased in the medial segment after the injection of prostaglandin E₁ (p<0.05) in all cases of both groups. On the other hand, they were clearly decreased in the posterior segment after the injection of prostaglandin E₁ (p<0.05) in both groups. There were no statistical differences in the CT numbers in the anterior and lateral segments in all patients. In addition, the CT numbers of anterior and posterior segments showed high attenuation compared with the medial and lateral segments in group A without prostaglandin E₁. 2) SD numbers: The SD numbers, which are an index of the homogeneous enhancement, were significantly decreased in the posterior, medial and lateral segments after the injection of prostaglandin E₁ (p<0.01, p<0.05, p<0.01, respectively) in both groups. There were no significant differences in the SD numbers in the anterior segment regardless of the injection of prostaglandin E₁ in all cases. Conclusion: CTAP with injection of prostaglandin E₁ makes contrast enhancement of liver parenchyma more homogeneously than the conventional procedure, and it may be a useful technique for the detection of liver tumors.
Correspondence to	Yutaka Abe, MD, Department of Radiology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan y-abe@nms.ac.jp